Private Wealth Management Group’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.06K Hold
73
– – ﹤0.01% 703
2026
Q2
$5.71K Hold
73
– – ﹤0.01% 798
2026
Q1
$4.72K Hold
73
– – ﹤0.01% 791
2025
Q4
$4.91K Hold
73
– – ﹤0.01% 780
2025
Q3
$5.35K Hold
73
– – ﹤0.01% 767
2025
Q2
$3.8K Hold
73
– – ﹤0.01% 866
2025
Q1
$4.66K Hold
73
– – ﹤0.01% 763
2024
Q4
$3.49K Hold
73
– – ﹤0.01% 887
2024
Q3
$4.18K Hold
73
– – ﹤0.01% 797
2024
Q2
$3.82K Sell
73
-74
-50% -$3.24K ﹤0.01% 816
2024
Q1
$5.98K Sell
147
-24
-14% -$900 ﹤0.01% 568
2023
Q4
$6.32K Buy
+171
New +$6.44K ﹤0.01% 551

Other funds holding HALO

Private Wealth Management Group's HALO Position: Q3 2026 in Review

Private Wealth Management Group held its Halozyme (HALO) position steady in Q3 2026 at 73 shares worth $8.06K. The position accounts for ﹤0.01% of the portfolio, ranked #703.

Private Wealth Management Group first reported a position in HALO in Q4 2023 and has held it in 12 quarters since. 777 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

  • Private Wealth Management Group held 73 shares of Halozyme worth $8.06K as of Q3 2026.
  • Private Wealth Management Group left its Halozyme share count unchanged in Q3 2026.
  • Halozyme made up ﹤0.01% of Private Wealth Management Group's portfolio in Q3 2026, its #703 holding.
  • Private Wealth Management Group first reported a position in Halozyme in Q4 2023 and has held it in 12 quarters since.
  • 777 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on Private Wealth Management Group's 13F filing for Q3 2026, filed 19 Oct 2026.